Faculty profile

Afsaneh Lavasanifar

ResearcherUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Afsaneh Lavasanifar

Researcher

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
24 publications in the last five years, latest in 2026.
Senior (last) author on 11 recent papers, a sign of leading a research group.
Principal investigator on 13 research grants (7 CIHR, 6 NSERC), most recently in 2024.
Supervised 3 trainees who won CIHR awards, most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

161

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Nanotechnology Drug Delivery Dna Repair Chemotherapy Drug Targeting Cancer Chemotherapy Drug Resistance Sirna Delivery

Latest papers

Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancer.
Oncoimmunology · 2026
In Vivo Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.
Cancer investigation · 2026 · senior author
The effect of cryoprotectant and storage conditions on the aggregation of poly(ethylene glycol)-poly(α-benzyl carboxylate-ε-caprolactone) nanoparticles.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026 · senior author

All 161 publications

Latest funding

Polynucleotide kinase/phosphatase: its role in DNA strand break repair and a potential cancer therapeutic target
CIHR · 2025 · Co-investigator
$1,005,976
CBS/CSPS-2026 Conference: Next Generation Biomaterials and Pharmaceutical Technologies for All
CIHR · 2025 · Co-investigator
$20,000
Nano-carriers of novel inhibitors of DNA repair for enhanced therapy in unresectable lung cancer
CIHR · 2024 · Nominated PI
$868,275

All 27 grants and awards

From the 150 most recent of 161 publications.

Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancer.

Azimi A, Rahmati A, Shahbaz S, Elahi Z, Zahiriabyaneh A, Cao J, Padua EL, Church C, Alimo ET, Lavasanifar A, Walker J, Elahi S

Oncoimmunology2026

DOI: 10.1080/2162402x.2026.2682649 PMID: 42228003

In Vivo Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.

Kazemi M, Emami J, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A

Cancer investigation2026Senior author

DOI: 10.1080/07357907.2026.2675649 PMID: 42324122

The effect of cryoprotectant and storage conditions on the aggregation of poly(ethylene glycol)-poly(α-benzyl carboxylate-ε-caprolactone) nanoparticles.

Sarrami N, Honary S, Vakili MR, Lavasanifar A

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques2026Senior author

DOI: 10.3389/jpps.2026.15721 PMID: 41769061

Liposomal Delivery of Pyronaridine as a Repurposed Inhibitor of ERCC1/XPF for the Sensitization of Colorectal Cancer Cells to Platinum Chemotherapeutics.

Mehinrad P, Abdelfattah A, Shafaati T, Emami J, Donnelly J, West FG, Weinfeld M, Lavasanifar A

Molecular pharmaceutics2026Senior author

DOI: 10.1021/acs.molpharmaceut.5c01645 PMID: 41466566

Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.

Kc R, Nasrullah M, Sandhu G, Kucharski C, Lavasanifar A, Uludag H

Biomaterials advances2025

DOI: 10.1016/j.bioadv.2025.214394 PMID: 40555157

Protein corona composition modulates uptake of polymeric micelles by colorectal cancer cells.

Sirazum M, Abdelfattah A, Pandey P, Ashkarran A, Tadjiki S, Sharifi S, Gharibi H, Saei AA, Mahmoudi M, Lavasanifar A

Nanoscale advances2025Senior author

DOI: 10.1039/d4na01085j PMID: 40612094

Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics.

Mehinrad P, Abdelfattah A, Sadat SMA, Shafaati T, Elmenoufy AH, Jay D, West F, Weinfeld M, Lavasanifar A

Drug delivery and translational research2025Senior author

DOI: 10.1007/s13346-024-01782-9 PMID: 39878858

Development, characterization, and in vitro evaluation of poly(ethylene oxide)-block-poly(ε-caprolactone)-α-tocopheryl succinate micelles as a novel nanocarrier for rapamycin delivery.

Binkhathlan Z, Alshememry AK, Balkhair AM, Ali R, Alhudaithi SS, Alobid S, Qamar W, Aodah AH, Vakili MR, Lavasanifar A

International journal of pharmaceutics: X2025Senior author

DOI: 10.1016/j.ijpx.2025.100341 PMID: 40521159

Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells.

Amiri M, Jafari S, Lavasanifar A, Molavi O, Montazersaheb S

Current pharmaceutical biotechnology2025

DOI: 10.2174/0113892010280336240227062954 PMID: 38482616

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice.

Sarrami N, Nelson B, Leier S, Wilson J, Chan C, Meens J, Komal T, Ailles L, Wuest M, Schultz M, Lavasanifar A, Reilly RM, Wuest F

EJNMMI radiopharmacy and chemistry2024

DOI: 10.1186/s41181-024-00313-8 PMID: 39589608

Something wrong or missing on this profile? Suggest a correction

Afsaneh Lavasanifar

Research

Latest papers

Latest funding

Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancer.

In Vivo Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.

The effect of cryoprotectant and storage conditions on the aggregation of poly(ethylene glycol)-poly(α-benzyl carboxylate-ε-caprolactone) nanoparticles.

Liposomal Delivery of Pyronaridine as a Repurposed Inhibitor of ERCC1/XPF for the Sensitization of Colorectal Cancer Cells to Platinum Chemotherapeutics.

Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.

Protein corona composition modulates uptake of polymeric micelles by colorectal cancer cells.

Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics.

Development, characterization, and in vitro evaluation of poly(ethylene oxide)-block-poly(ε-caprolactone)-α-tocopheryl succinate micelles as a novel nanocarrier for rapamycin delivery.

Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells.

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice.

Polynucleotide kinase/phosphatase: its role in DNA strand break repair and a potential cancer therapeutic target

CBS/CSPS-2026 Conference: Next Generation Biomaterials and Pharmaceutical Technologies for All

Nano-carriers of novel inhibitors of DNA repair for enhanced therapy in unresectable lung cancer

Studies on a broadly-protective novel lipopeptides-based intranasal vaccine for SARS-CoV2

"Polyplex-In-Hydrophobic-Core" Micelles: Reduction to Commercial Practice

Targeted delivery of novel inhibitors of DNA repair and combination treatments for the modulation of therapeutic response against metastatic colorectal cancer

Nano-delivery systmes for targeted co-delivery of topoisomerase toxin SN-38 and its novel synergistic inhibitor of DNA repair in colorectal cancer.

Development of stimuli deformable lipid/polymer hybrid nano-materials for drug delivery applications

Nanodelivery systems for targeted inhibition of DNA repair in the treatment of unresectable lung cancer

Nano-delivery of novel inhibitors of polynucleotide kinase/phosphatase (PNKP) for tumor targeted sensitization of colorectal cancer to DNA damage.

Frequent collaborators

Michael Weinfeld

Hasan Uludag

Frank Wuest

James Shapiro

Xiaoyan Jiang

Shokrollah Elahi

Christopher Venner

John Seubert

Larry Unsworth

Jack Tuszynski

Frederick West

Shima Shahbaz

Laurie Ailles

Paul Jurasz

Afsaneh Lavasanifar

Research

Latest papers

Latest funding

Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancer.

In&#xa0;Vivo Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.

The effect of cryoprotectant and storage conditions on the aggregation of poly(ethylene glycol)-poly(&#x3b1;-benzyl carboxylate-&#x3b5;-caprolactone) nanoparticles.

Liposomal Delivery of Pyronaridine as a Repurposed Inhibitor of ERCC1/XPF for the Sensitization of Colorectal Cancer Cells to Platinum Chemotherapeutics.

Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.

Protein corona composition modulates uptake of polymeric micelles by colorectal cancer cells.

Nano-delivery of a novel inhibitor of ERCC1-XPF for targeted sensitization of colorectal cancer to platinum-based chemotherapeutics.

Development, characterization, and in vitro evaluation of poly(ethylene oxide)-block-poly(&#x3b5;-caprolactone)-&#x3b1;-tocopheryl succinate micelles as a novel nanocarrier for rapamycin delivery.

Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells.

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice.

"Polyplex-In-Hydrophobic-Core" Micelles: Reduction to Commercial Practice

Development of stimuli deformable lipid/polymer hybrid nano-materials for drug delivery applications

Frequent collaborators

Michael Weinfeld

Hasan Uludag

Frank Wuest

James Shapiro

Xiaoyan Jiang

Shokrollah Elahi

Christopher Venner

John Seubert

Larry Unsworth

Jack Tuszynski

Frederick West

Shima Shahbaz

Laurie Ailles

Paul Jurasz

In Vivo Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.

The effect of cryoprotectant and storage conditions on the aggregation of poly(ethylene glycol)-poly(α-benzyl carboxylate-ε-caprolactone) nanoparticles.

Development, characterization, and in vitro evaluation of poly(ethylene oxide)-block-poly(ε-caprolactone)-α-tocopheryl succinate micelles as a novel nanocarrier for rapamycin delivery.